Tissue Banking Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Description
Tissue Banking Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Tissue banks recover, process, store, and distribute tissue for transplantation. Research in the field of tissue preservation at low temperature and high clinical success of transplanted tissue led to increase in the use of stored tissue in major burn and trauma patients. Increased demand for allografts resulted in the establishment of in-house tissue banking activity at major burns centers. Tissue banking organization is a complex system and needs high technical expertise and skilled personnel for proper functioning in a dedicated facility.
Market Dynamics
Increasing surgical demands for allografts, demand for bone graft in hip replacements, and femoral head allografts, and increasing incidences of burn patients are the main factors for the growth of the tissue banking market. According to WHO March 2018 report, about 180,000 deaths are caused by burns every year, majority of the cases occur in low and middle income countries. Moreover, aging population is prone to chronic diseases, such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy.
Private and public organizations are playing crucial role in fulfilling the gap between demand and supply of tissue. For instance, in 2021, MTF Biologics distributed over 550,000 tissue grafts, which was made possible through the selfless donation by 5,700 individuals. These transplantable tissues helped to heal an estimated 400,000 lives in over 50 countries.
Dearth of highly trained professionals to maintain the tissue banks is the major restraining factor for growth of the tissue banking market. For instance, according to ALZFORUM 2018 report, over the last 50 years, the number of neuropathologists on staff at the Netherlands Brain Bank dropped from 65 to about 15.
Key features of the study:
This report provides in-depth analysis of the tissue banking market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global tissue banking market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological upgradation, market expansion, and marketing tactics
The global tissue banking market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for tissue banking market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Tissue Banking Market, By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
Global Tissue Banking Market, By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Global Tissue Banking Market, By Region:
North America
By Country:
U.S.
Canada
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Africa
By Country:
South Africa
Central Africa
North Africa
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Company Profiles
AbD Serotec*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
AMS Biotechnology Limited
BioLife Solutions, Inc.
Beckman Coulter, Inc.
BioCision LLC
BioStorage Technologies, Inc.
Custom BioGenic Systems
Eppendorf AG
EMD Millipore Corporation
Fisher BioServices, Inc.
Genzyme Corporation
Hamilton Company
Merck KGaA
PHC Corporation
Teva Pharmaceutical Industries Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
Tissue banks recover, process, store, and distribute tissue for transplantation. Research in the field of tissue preservation at low temperature and high clinical success of transplanted tissue led to increase in the use of stored tissue in major burn and trauma patients. Increased demand for allografts resulted in the establishment of in-house tissue banking activity at major burns centers. Tissue banking organization is a complex system and needs high technical expertise and skilled personnel for proper functioning in a dedicated facility.
Market Dynamics
Increasing surgical demands for allografts, demand for bone graft in hip replacements, and femoral head allografts, and increasing incidences of burn patients are the main factors for the growth of the tissue banking market. According to WHO March 2018 report, about 180,000 deaths are caused by burns every year, majority of the cases occur in low and middle income countries. Moreover, aging population is prone to chronic diseases, such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy.
Private and public organizations are playing crucial role in fulfilling the gap between demand and supply of tissue. For instance, in 2021, MTF Biologics distributed over 550,000 tissue grafts, which was made possible through the selfless donation by 5,700 individuals. These transplantable tissues helped to heal an estimated 400,000 lives in over 50 countries.
Dearth of highly trained professionals to maintain the tissue banks is the major restraining factor for growth of the tissue banking market. For instance, according to ALZFORUM 2018 report, over the last 50 years, the number of neuropathologists on staff at the Netherlands Brain Bank dropped from 65 to about 15.
Key features of the study:
This report provides in-depth analysis of the tissue banking market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global tissue banking market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological upgradation, market expansion, and marketing tactics
The global tissue banking market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for tissue banking market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Tissue Banking Market, By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
Global Tissue Banking Market, By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Global Tissue Banking Market, By Region:
North America
By Country:
U.S.
Canada
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Africa
By Country:
South Africa
Central Africa
North Africa
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Company Profiles
AbD Serotec*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
AMS Biotechnology Limited
BioLife Solutions, Inc.
Beckman Coulter, Inc.
BioCision LLC
BioStorage Technologies, Inc.
Custom BioGenic Systems
Eppendorf AG
EMD Millipore Corporation
Fisher BioServices, Inc.
Genzyme Corporation
Hamilton Company
Merck KGaA
PHC Corporation
Teva Pharmaceutical Industries Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
152 Pages
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product
- Market Snippet, By Tissue Type
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Technological Advancements
- Supply Chain Analysis
- Regulatory Landscape
- PEST Analysis
- 4. Global Tissue Banking Market, By Product, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Media and Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Cryopreservation Equipment
- Quality Control Equipment
- Thawing Equipment
- Others
- 5. Global Tissue Banking Market, By Tissue Type, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Bone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Brain and Spinal Cord
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Cornea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Heart Valves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 6. Global Tissue Banking Market, By Region, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
- North America
- Market Size and Forecast, By Product, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Tissue Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Tissue Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Tissue Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Product, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Tissue Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Product, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Tissue Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Northern Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Product, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Tissue Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
- 7. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- AbD Serotec
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- AMS Biotechnology Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- BioLife Solutions, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Beckman Coulter, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- BioCision LLC
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- BioStorage Technologies, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Custom BioGenic Systems
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Eppendorf AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- EMD Millipore Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Fisher BioServices, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Genzyme Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Hamilton Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck KGaA
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- PHC Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Analyst Views
- 8. Section
- References
- Research Methodology
- About Us and Sales Contact
- *Browse 38 market data tables and 27 figures on "Tissue Banking Market” - Global forecast to 2028”.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
